Samsung Medical: Intends to issue H shares and list on The Stock Exchange of Hong Kong Limited.

Sina Finance reported on March 30th that Samsung Medical announced that the company held the 28th meeting of the sixth board of directors on March 30th, 2026, and approved the relevant proposals such as "Proposal on the company's overseas public offering of shares and listing on the main board of the Hong Kong Stock Exchange" and "Proposal on the company's overseas public offering of shares and listing on the main board of the Hong Kong Stock Exchange". The company plans to issue H shares on the main board of the Hong Kong Stock Exchange to meet the funding needs for business development and enhance its international level. This plan still needs to be reviewed by the shareholders' meeting and obtain record filing, approval, and/or authorization from relevant regulatory authorities. Currently, the company is discussing specific details with intermediary institutions, and the issuance plan has not been finalized yet.